D.E. Shaw & Co
INGN icon

D.E. Shaw & Co’s Inogen INGN Stock Holding History

D.E. Shaw & Co’s Portfolio INGN Stock Details INGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-61,100
Closed -$2.93M – 4047
2019
Q3 		$2.93M Buy
61,100
+50,000
+450% +$2.61M ﹤0.01% 2068
2019
Q2 		$741K Buy
+11,100
New +$845K ﹤0.01% 2858
2019
Q1 		– Sell
-15,000
Closed -$1.86M – 3741
2018
Q4 		$1.86M Sell
15,000
-9,700
-39% -$1.6M ﹤0.01% 2219
2018
Q3 		$6.03M Buy
+24,700
New +$5.71M 0.01% 1450

Other funds holding INGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co's INGN Position: Q2 2026 in Review

D.E. Shaw & Co reduced its Inogen (INGN) stake by 20% in Q2 2026, selling an estimated $62.7K and leaving 37,171 shares worth $240K. The position accounts for ﹤0.01% of the portfolio, ranked #4498.

D.E. Shaw & Co first reported a position in INGN in Q1 2015 and has held it in 26 quarters since. The position peaked at $24.9M in Q4 2019. 129 funds tracked by Wall St. Rank hold INGN as of Q2 2026.

  • D.E. Shaw & Co held 37,171 shares of Inogen worth $240K as of Q2 2026.
  • D.E. Shaw & Co sold 9,472 Inogen shares in Q2 2026, an estimated $62.7K.
  • Inogen made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #4498 holding.
  • D.E. Shaw & Co first reported a position in Inogen in Q1 2015 and has held it in 26 quarters since.
  • D.E. Shaw & Co's Inogen position peaked at $24.9M in Q4 2019.
  • 129 funds tracked by Wall St. Rank held Inogen as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.